Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Toxic Anterior Segment Syndrome (TASS): studying an outbreak].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2009
Same author

[Ocular manifestations of systemic diseases].

Anales del sistema sanitario de Navarra·2009
Same author

[Bilateral traumatic retinopathy associated to whiplash injury].

Archivos de la Sociedad Espanola de Oftalmologia·2004
Same author

[Cytomegalovirus retinitis after highly active antiretroviral therapy: a case report].

Archivos de la Sociedad Espanola de Oftalmologia·2002
Same author

[Xenon light induced phototoxic lesions].

Archivos de la Sociedad Espanola de Oftalmologia·2001
Same journal

[Subacute meningoencephalitis following intravesical BCG instillation immunotherapy].

Anales del sistema sanitario de Navarra·2026
Same journal

[Treatment with dabrafenib and trametinib in an intrahepatic cholangiocarcinoma harboring a BRAF V600E mutation].

Anales del sistema sanitario de Navarra·2026
Same journal

[Efficiency after integrating a hospital with a 'new management model'].

Anales del sistema sanitario de Navarra·2026
Same journal

[Anales del Sistema Sanitario de Navarra in 2025: Progress continues].

Anales del sistema sanitario de Navarra·2026
Same journal

Qualitative evaluation of a community intervention in educational centres: Opinion of the professionals involved.

Anales del sistema sanitario de Navarra·2026
Same journal

[Unequal impact of COVID-19 on mortality in long-term care homes across health areas of Castilla-La Mancha (Spain)].

Anales del sistema sanitario de Navarra·2026
See all related articles

Related Experiment Videos

[Diabetic macular edema].

J Andonegui Navarro1, L Jiménez Lasanta

  • 1Servicio de Oftalmología, Hospital de Navarra, Pamplona 31008, Spain. jandonen@cfnavarra.es

Anales Del Sistema Sanitario De Navarra
|January 27, 2009
PubMed
Summary
This summary is machine-generated.

Diabetic macular edema causes vision loss in diabetics. This review covers its causes, symptoms, diagnosis, and treatments, highlighting new advancements for ophthalmologists.

Related Experiment Videos

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Diabetology

Context:

  • Diabetic macular edema (DME) is a leading cause of vision impairment in individuals with diabetes mellitus.
  • The management of DME presents a significant challenge due to its complexity and evolving diagnostic and therapeutic landscape.

Purpose:

  • To provide a comprehensive overview of diabetic macular edema.
  • To detail the pathophysiology, clinical manifestations, classification, diagnosis, and treatment of DME.
  • To emphasize recent advancements in diagnostic techniques and therapeutic strategies for DME.

Summary:

  • This article reviews the multifaceted aspects of diabetic macular edema, including its underlying mechanisms and clinical presentation.
  • It outlines current diagnostic approaches and classifies the condition, with a focus on novel methods.
  • The review extensively discusses various treatment options, emphasizing emerging therapeutic alternatives.

Impact:

  • Enhances understanding of diabetic macular edema for ophthalmologists and healthcare providers.
  • Facilitates informed clinical decision-making by presenting updated diagnostic and treatment information.
  • Contributes to improved patient outcomes by highlighting the latest advancements in DME management.